Search

Displaying results 51 - 60 of 78 in total
  1. Indication

    Advanced Endometrial Cancer

    go.drugbank.com/conditions/DBCOND0050728
    Drugs: Carboplatin · Doxorubicin · Pembrolizumab
  2. Indication

    Lung Cancer, Nonsmall Cell, Stage IIIA

    go.drugbank.com/conditions/DBCOND0150709
    Drugs: Atezolizumab · Gemcitabine · Pembrolizumab
  3. Indication

    Metastatic cutaneous squamous cell carcinoma

    go.drugbank.com/conditions/DBCOND0017288
    Drugs: Cemiplimab · Cosibelimab · Pembrolizumab
  4. Indication

    Locally Advanced Cutaneous Squamous Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0133965
    Drugs: Cemiplimab · Cosibelimab · Pembrolizumab
  5. Indication

    Unresectable Locally Advanced Triple-negative Breast Cancer

    go.drugbank.com/conditions/DBCOND0154926
    Drugs: Pembrolizumab · Sacituzumab govitecan
  6. Indication

    Refractory Primary Mediastinal Large B-Cell Cell Lymphoma

    go.drugbank.com/conditions/DBCOND0135857
    Drugs: Epcoritamab · Lisocabtagene maraleucel · Pembrolizumab
  7. Indication

    Metastatic Biliary Tract Cancer

    go.drugbank.com/conditions/DBCOND0046438
    Drugs: Durvalumab · Pembrolizumab · Zanidatamab
  8. Indication

    Metastatic HER2-positive Adenocarcinomas of the Gastroesophageal Junction

    go.drugbank.com/conditions/DBCOND0144316
    Drugs: Pembrolizumab · Trastuzumab deruxtecan
  9. Indication

    Metastatic Triple Negative Breast Cancers

    go.drugbank.com/conditions/DBCOND0142223
    Drugs: Datopotamab deruxtecan · Pembrolizumab · Sacituzumab govitecan
  10. Indication

    Platinum-resistant Fallopian Tube Cancer

    go.drugbank.com/conditions/DBCOND0153829
    Drugs: Mirvetuximab soravtansine · Pembrolizumab · Relacorilant